John T said...
Undoubtably there will be more cases of advanced pc that are discovered and more deaths due to pc. As I understand the recommendations they do not recommend mass screenings, but leave it to the patient and doctor to decide if screening is appropriate. All at risk men, African Americans, those with a family history of breast or prostate cancer should be screened. Before screening a patient should be told of the risks and benefits of screening before the psa box on the lab order is checked off.
I have no problem with this as it is the patient's decision along with a doctor's recommendation. My only issue is that this may be a way that Medicare and insurance companies will stop paying for screening and that would be unacceptable.
I see this as no different than screening for colon concer or getting an Xray for lung cancer. These are optional and a patient must decide if he wants them.
JohnT
JohnT,
What you say is not correct. The recommendation does not exclude all at risk men, African-Americans and those with a family history of PCa. Consultation of those uninformed men with their physicians leave them at the mercy of their opinions. Hardly unbiased when the Task Force recommends that those physicians do not offer PSA testing to asymptomatic men. This is the wording of the proposed recommendation:
"This recommendation applies to men in the U.S. population that do not have symptoms that are highly suspicious for prostate cancer, regardless of age, race, or family history."
"This recommendation applies to men in the general U.S. population. Older age is the strongest risk factor for development of prostate cancer. However, a more favorable balance of benefits and harms for PSA-based screening does not accompany this increase in risk. Across age ranges, African American men and men with a family history of prostate cancer have an increased risk for developing and dying from prostate cancer compared with other men. However, the observed risk differences for race/ethnicity or family history are each relatively small when compared with the risk differences seen with increasing age (1), and there are no data that suggest that the net benefit of PSA-based screening is altered by race or family history."
This is an indication of how far off this recommendation is. African-Americans die at more than double the rate of Caucasians but in their wisdom the Task Force considers it to be small potatoes...As a matter of fact it considers death from PCa as small potatoes.
RalphV